Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
A A C C A C A C C A C C A A C A A A A A A A A A A Y A
A61P A61K C07D C07F A61K C07D A61K C07D C07D A61K C07D C07D A61K A61K C07D A61K A61K A61K A61K A61K A61K A61K A61P A61P A61K Y02P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional
Charles A. Allan C. Sachin V. Pamela L. Todd W. David A. Kevin R. Jean C. Rolf Dachun Clarence J. Kathy Mark A. Douglas K. Christopher E. Tammie K. Michael D. Daniel D. Wenke Seble H. John T. Yi Lissa T. Charles W. Mary E. David A. Ryan G. William A. John K. Warren M.
Flentge Krueger Patel Donner Rockway DeGoey Woller Califano Wagner Liu Maring Sarris Matulenko Hutchinson Motter Jinkerson Tufano Caspi Li Wagaw Randolph Gao Nelson Hutchins Bellizzi Betebenner Keddy Carroll Pratt Kati